PTPA and lung carcinoma: This conclusion is consistent with a study reporting that PP2A drives RIP1-dependent necroptosis in lung cancer [28], and our results highlight that PP2A merits further exploration as an excellent candidate for inducible switching between two PCDs pathways known to be active in the pathogenesis of ALI.